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Abstract
Background: Craniomaxillofacial fibrous dysplasia (FD) is a benign bone lesion characterized by facial disfigurement
and functional impairment. The aim of this study was to characterize the epidemiological and clinical features
of craniomaxillofacial FD by presenting data from a representative Chinese population during a 15-year period
(1994–2009).
Method: The craniomaxillofacial disease registries of two Chinese tertiary referral hospitals (Shanghai Ninth
People’s Hospital and Stomatological hospital of Jiangsu Province) were searched and reviewed to collect relevant
information for patients with craniomaxillofacial FD between Jan.1994 and Dec.2009. All included cases were
further analyzed with regard to associated epidemiological and clinicopathological variables.
Results: A total number of 266 cases with definitive diagnosis were identified with 219 primary cases and 47
recurrent cases. There were 111 males and 155 females with a male to female ratio of 0.716:1. They were clinically
categorized into three groups: monostotic (71.1%), polysotic (27.4%) and Albright syndrome (1.5%). Maxilla alone
or with adjacent bones was the most common affected site. The serum alkaline phosphatase (ALP) in patients
was much higher than that in healthy control, whereas comparable between primary patients and recurrent
ones. Three patients (3/266, 1.1%) with polysotic lesions underwent spontaneous malignant transformation into
osteosarcoma. The majority of patients underwent conservative surgery, while the others received radical
resection with or without reconstruction.
Conclusions: Craniomaxillofacial FD is a rare bony disorder with defined epidemiological and clinicopathological
features in Chinese population. Further investigations are warranted to establish the optimized timing, treatment
strategy and prognostic prediction for this clinical entity.
Keywords: Craniomaxillofacial fibrous dysplasia, Epidemiology, Diagnosis, Treatment
Introduction
Fibrous dysplasia (FD) is a benign bone lesion charac-
terized by the replacement of normal bone structure
with abnormal fibro-osseous connective tissue [1]. It
accounts for about 2-3% of bone-derived tumors and
usually occurs throughout the skeletons around the body
with a predilection for craniomaxillofacial bones [2].
Craniomaxillofacial FD usually begins in childhood and
slowly progresses through puberty, resulting in deva-
stating facial deformities and functional deficits [3].
These lesions develop not only in single bone (mon-
stotic) but also in multiple bones (polystotic), sometimes
concomitantly associated with skin pigmentation and
endocrine disturbances (McCune-Albright syndrome).
Activating mutations of the alpha subunit of stimulatory
G protein gene(GNAS) at Arg201 and increased prolif-
eration and inappropriate differentiation in the osteo-
blastic cells has been identified to be implicated in the
FD pathogenesis [4].
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In craniomaxillofacial region, maxilla is more com-
monly affected than mandible and usually involves adja-
cent bones such as sphenoid, zygoma and frontal bone.
These patients often present with a painless, slowly
enlarging and hard swelling in affected bones. Its over-
growth tends to result in facial asymmetry, disfigure-
ment, malocclusion, orbital dystopia and exophthalmos,
largely depending on anatomical sites and structure
involved [5]. Radiographic characteristics include cystic,
sclerotic or pagetoid, often a typical ground-glass
appearance with ill-defined margins. Under the micro-
scope, these lesions usually show irregularly shaped tra-
beculae of immature woven bone in compact stroma of
interlacing collagen fibers without sharp demarcation.
Various treatment strategies are available for these
lesions, ranging from watchful expectancy for arrested
growth after puberty to conservative therapy (recontour-
ing, curettage or trimming), to radical resection followed
by immediate reconstruction. The prognosis for patients
with craniomaxillofacial FD is usually favorable, although
spontaneous malignant transformation is rarely reported
in the literature [6].
However, the lack of information regarding the epi-
demiological and clinical characteristics of craniomaxil-
lofacial FD complicates in-depth understanding of these
entities and impedes advances for their diagnosis and
treatment. Furthermore, to the best of our knowledge,
no information about the epidemiological data regarding
craniomaxillofacial FD from Chinese population has
been reported thus far, which necessitates an epidemio-
logical and clinical investigation into this disease. In the
present study, we retrospectively reviewed and presented
the epidemiological and clinical data of craniomaxillofa-
cial FD from two Chinese tertiary referral hospitals over
the past 15 years (1994–2009) in order to highlight the
demographic, clinical and pathological characteristics in
a large representative Chinese population. These data
might also provide valuable information for comparison
with other epidemiological studies from different geo-
graphical site and races.
Patients and methods
Both of craniomaxillofacial disease registries of Shanghai
Ninth People’s Hospital and Stomatological Hospital
of Jiangsu Province were reviewed to retrieve relevant
information about patients with craniomaxillofacial FD
receiving surgeries during the past 15 years (1994–2009).
Inclusion criteria comprised the patients with detailed data
including precise location, definitive diagnosis by clinical
manifestations, radiographic findings and histopathology.
The medical charts or records of these enrolled patients
were retrieved and subjected to further review to obtain
information regarding patient demographics, clinicopatho-
logical features, treatment modalities and outcomes. This
clinical retrospective study was approved by both institu-
tional academic committees and performed in accordance
with guidelines of the Declaration of Helsinki. Informed
consent was obtained from patients or their guardians.
The definitive diagnosis of craniomaxillofacial FD was
made largely based on clinical symptoms and signs,
radiographic features and postoperative pathological
findings. In this study, diseases affecting two or more
segments of one bone in the craniofacial region were
classified as monostotic lesions, while abnormal growths
involving multiple bones in this area were defined
as polyostotic lesions. The patients with characteristic
triad conditions were diagnosed as McCune-Albright
syndrome. Additionally, the recurrent cases were defined
as the patients sought to receive one more treatment
following their initial surgeries.
All patients included here were treated by surgery
which can be divided into two main categories: conser-
vative surgery (partial resection: trimming, recontouring
and curettage) and radical surgery (complete resection
and/or simultaneous reconstruction). The aims of surgi-
cal treatment for these patients were to correct the func-
tional problems (such as optic nerve compression with
progressive deterioration of vision when orbit involved
and severe skeletal malocclusion when jaws affected)
and achieve aesthetic improvement when facial deform-
ities became evident. Therefore, the main surgical indi-
cations for most patients in our cohort were severe
facial deformities, devastating functional disturbance and
avoidance of potential malignant transformation. These
patients were recommended to participate in the long-
term follow-up by clinical and radiographic examina-
tions (CT scan) at regular intervals.
All relevant data available from every patient were col-
lated and tabulated using Microsoft Excel. Descriptive
statistical analysis was performed for the variables of
interest. Difference between experimental groups was
assessed by Student’s t-test using SPSS software package
13.0. p<0.05 was considered statistically significant.
Results
Our registry searches have identified a total number
of 266 patients with craniomaxillofacial FD treated at
both institutions between 1994 and 2009 according to
the preset inclusion criteria. There were 219 primary
cases and 47 recurrent cases, each accounting for 82.3%
(219/266) and 17.7% (47/266), respectively. Most recur-
rent cases were treated previously in other clinics and
then referred to our institutions for further treatment
mainly due to apparent disease regrowth and/or unsatis-
fied facial profile. All these patients were treated by con-
servative or radical surgeries and definitive diagnoses
were further confirmed by postoperative histopatho-
logical evidence.
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Among 266 patients, there were 111 males and 155
females with a male to female ratio of 0.716:1, an indica-
tive of a female predominance. The average age of these
patients at the time of receiving surgeries was 27.1 years
(range 9–70 years). Age distribution as shown in Figure 1
indicated that most patients underwent surgical treat-
ment at the second and third decades of life, each
accounting for 34.9% (93/266) and 33.1% (88/266).
Moreover, the time intervals between initial diagnosis
and surgical treatment ranged from a few weeks to more
than 20 years. Approximately 50% of these patients
underwent surgery less than 5 years after initial diag-
nosis. With regard to the primary sites of disease,
109 patients involved the left side, 138 affecting the
right side and 19 affecting both sides. According to the
X-ray and CT scan images prior to surgery, maxilla was
identified as the most common bone involved, fol-
lowed by mandible, zygoma, zygomaticomaxillary com-
plex and multiple bones in descending sequence as
shown in Figure 2. Clinical subtypes of these patients
were then accordingly categorized as monostotic lesions
(189, 71.1%), polysotic lesions (73, 27.4%) and Albright
syndrome (4, 1.5%). The concentrations of serum ALP
(alkaline phosphatase) available for 192 patients with
craniomaxillofacial FD ranged from 34 to 629 U/L with
an average 125.1 U/L, which were significantly higher
than those in both age-and sex-matched healthy controls
as indicated in Figure 3 (average 73.1 U/L).
As regard to these recurrent cases, they all have
received conservative surgeries before they sought one
more treatment at our institutions, whereas no recurrence
was found in patients who previously underwent radical
resection. Fourteen were males and thirty-three were
females. The mean age of these recurrent patients was
28.6 years (16–69 years). They can be categorized as
28 monostotic lesions, 18 polystotic lesions and 1 Alb-
right syndrome. The time intervals between initial surgery
and further surgical treatment at our tertiary referral
hospitals ranged from 6 to 192 months (average 63.7
months). The average serum ALP was 131.7 U/L in such
patient group, which was much higher than healthy con-
trols(average 73.1 U/L, P<0.01). Moreover, such para-
meters in recurrent cases appeared a little higher than
those in primary cases, although no statistical significant
difference was found (Figure 4).
Among 266 patients, 3 patients (3/266, 1.1%) were
found to undergo spontaneous malignant transforma-
tion of fibrous dysplasia into osteosarcoma which were
confirmed by postoperative pathological examinations as
evidenced by the existence of both fibrous dysplasia and
osteosarcoma. All malignant diseases occurred in maxilla
Figure 1 Age distribution of patients when initially diagnosed
as craniomaxillofacial FD.
Figure 2 Primary site distribution of patients with
craniomaxillofacial FD.
Figure 3 Serum ALP concentration in patients with
craniomaxillofacial FD and healthy controls.
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and adjacent zygoma and sphenoid. The clinical sub-
types of these patients were initially categorized as poly-
ostotic. Medical records indicated that no patients had
history of prior radiotherapy and the concentrations of
serum ALP were 65, 323, 763, respectively. Two patients
died of tumor and one remained alive after radical resec-
tion during the follow-up (6-23months).
The clinical presentation of craniomaxillofacial fibrous
dysplasia primarily depends the site, extent and nature
of these bone lesions. The most common clinical mani-
festation was gradual and painless swelling and then
resulting facial deformities and disfigurements and mal-
occlusion. Some patients can also present with proptosis,
diplopia, hearing loss, nasal obstruction and loss of
vision when various structures and areas were affected.
The plain radiographic features of craniomaxillofacial
fibrous dysplasia were non-specific and often presented
as radiolucent lytic lesion with homogenous ground-
glass appearance and ill-delineated borders. Computed
tomography (CT) provides better assessment of the
extent of bone involved. Both plain radiography and CT
scan were essential for diagnosis, treatment planning
and postoperative monitoring for this clinical entity in
our diagnosis-treatment regime.
All patients with craniomaxillofacial FD were received
surgeries either conservative or radical one largely
depending on the extent of bone involvement and
patients’ choices as listed in Table 1. The majority of
patients (87.9%) underwent conservative surgery includ-
ing trimming and recontouring of the affected bones,
while the others received radical resection with or with-
out reconstruction. No radiotherapy and chemotherapy
was routinely given prior or after operation. These
patients were routinely received regular follow-up to
examine the disease regrowth and potential spontaneous
malignant transformation.
Discussion
Fibrous dysplasia is a benign and rare bone disorder that
often affects the craniofacial skeleton [7]. It usually cause
significant morphological and functional disturbance,
such as malocclusion, devastating facial aesthetics, et al.
The main treatment goal and challenge for these
patients with craniomaxillofacial FD is to restore normal
facial cosmetics and correct the associated deformities
[8]. Therefore, the comprehensive understanding of
this clinical entity might be the prerequisite for its early
detection, accurate diagnosis, proper management and
prognostic prediction. To the best of our knowledge, this
study might for the first time provide comprehensive
epidemiological and clinicopathological information
about craniomaxillofacial FD in patients of Chinese
origin, which is of great value for clinicians to manage
this clinical entity efficiently and properly.
Previous reports have revealed that gender distribution
of fibrous dysplasia was inconsistent with varied ratios
among different populations. Kruse A. et al. reported a fe-
male to male ratio 3:1 in their Swiss series of 8 craniomax-
illofacial FD [3]. However, several others reported that it
appeared to occur equally in males and females, indicating
no sex predilection [9]. This discrepancy may be resulted
from limited number of patients examined or disease
susceptibility among different races. However, in this large
number of Chinese patients, female preponderance was
identified evidently. Fibrous dysplasia often begins in
childhood and progresses through puberty and arrests in
adolescence [10]. Our data indicated that the majority of
patients sought treatment in their second and third decade
of life. However, growth arrest for fibrous dysplasia
seemed unpredictable and continued growth during the
adulthood was frequently observed in the clinic, which
also can be evidenced from the fact that 43 patients
(18.2%) with over 40-years-old sought surgical treatments.
The etiology and molecular pathogenesis of abnormal
fibrous-osseous process in fibrous dysplasia has been
Figure 4 Serum ALP concentration in patients with primary and
recurrent FD.




Trimming & recontouring 214
Trimming + orthoganthic surgery 4
Navigation-assisted bone trimming 12
Radical surgery
Total resection without reconstruction 16
Total resection with Ti-plate/mesh reconstruction 4
Total resection with free bone graft 4
Total resection with flap reconstruction* 12
Note: * flap reconstructions included 10 vascularized fibular flap,
1 vascularized iliac flap and 1 costochondral graft.
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gradually unraveled. Activating mutation of the Gs-a
protein and increased interleukin-6 synthesis in osteo-
progenitor cells has been implicated in the initiation
and progression of these lesions [11,12]. Although this
entity was commonly regarded as benign, malignant
transformation to osteosarcoma, fibrosarcoma or chon-
drosarcoma was sporadically reported in decreased order
of frequency, approximately accounting for 0.4-1% per-
centage of all cases [13]. Prior radiotherapy was sug-
gested to be associated with malignant degeneration
[14]. In this patient group, three patients with polysotic
lesions (maxilla, zygoma and sphenoid affected) were
identified with sarcomatic transformation in the pre-
existing fibrous lesions. However, no prior radiological
exposure to these patients was recorded. Thus, the roles
of radiotherapy in malignant transformation remain fur-
ther investigation.
Although fibrous dysplasia may involve any bone
throughout the body, several bones including maxilla,
mandible, sphenoid, frontal and temporal bone were
usually affected alone or together. In the present study,
the relative numbers of patients with monostotic and
polyostotic disease are generally similar with literature
report, which the former accounted for 70% and the
later accounted for 30% [9]. Maxilla was identified as
the most commonly involved bone in the monstotic
lesions. These polystotic lesions usually affected the
adjacent bones separated by sutures especially the
zygoma and sphenoid.
The clinical presentation of craniofacial fibrous dyspla-
sia varies largely depending on the site, duration and
extent of lesion. Generally, it usually presents as a slowly-
enlarging, painless, immobile and hard swelling, thereby
resulting in facial asymmetry and disfigurement, mal-
occlusion Visual impairment and hearing loss occur
when the vital neurovascular structures are compressed
by enlarged lesions. The disease onset is often slow and
gradual, so that varied intervals between onset and treat-
ment were observed. A fraction of patients only sought
treatments when obvious facial deformities or functional
disturbance were present. Suddenly accelerated growth
and onset of pain in a longstanding quiescent lesion may
indicate the possibility of malignant transformation and
demands prompt examination and vigorous therapy
when necessary.
Diagnosis of fibrous dysplasia is based on clinical
examination, radiographic and histopathological find-
ings. Therapeutic options for craniomaxillofacial fibrous
dysplasia include wait and see, conservative surgery and
radical surgery [8]. Nevertheless, no consensus about op-
timal treatment strategy has been well established and
remains a matter of controversy. Surgical indications
usually include correction of craniofacial deformities and
treatment of functional disturbance. The timing for
surgical intervention for craniomaxillofacial FD has
always been debated, especially in growing children [15].
In earlier years, surgeons were recommended to wait
and defer all surgical procedures until the disease might
become stabilized or arrested after puberty. However,
the unpredictable growing process of lesions and grad-
ually devastating facial form and function imposed
to young children made such procrastination unaccept-
able. Early surgical intervention becomes necessary and
logical at such instances that these diseases obviously
affect patients’ facial esthetic and functions. Some
authors advocated conservative shaving and curettage as
the principal treatment of choice, largely due to slowly
growing process, possible growth arrest in adolescence
and associated morbidities with aggressive surgery
[16,17]. Recently, several authors argued that conserva-
tive approach can’t completely eliminate the diseased
bone and a high rate of recurrence or regrowth was
reported especially in younger patients. They emphasized
that radical resection and reconstruction for craniomax-
illofacial FD was feasible and logical, which permitted
the complete removal of lesions and avoided risk of
malignant changes [18,19]. However, in our patient
series, the overwhelming majority underwent conserva-
tive surgery including trimming, curettage and recon-
touring, whereas 36 patients (13.5%) received radical
resection with or without simultaneous reconstruction.
Although the consensus about treatment indications for
craniomaxillofacial FD has not been reached, our indica-
tions for surgery usually included severe facial disfigure-
ment (evident facial swelling and asymmetry) and
functional disturbance (continuous visual loss and severe
malocclusion) to achieve esthetic facial profile and func-
tional improvement. We believed that the choice be-
tween conservative and radical surgery depends on the
following factors: affected site, growth rate, cosmetic and
functional impairment, patient preference and surgeon’s
experience and multi-disciplinary team approach. The
treatment option for each patient should be indivi-
dualized to weigh the pro and cons of both surgical
approaches. We preferred the conservative surgery mainly
owing to the benign nature, growth trajectory, and
exceeding rarity of malignant transformation of fibrous
dysplasia. More importantly, the latest surgical progresses
especially the image-guided navigation-assisted surgery
greatly improved the postoperative results of conservative
surgery for patients as we and others reported before
[20,21]. However, it’s clear that the conservative approach
might not be suitable for all patients. When patients with
multiple recurrences, severe facial disfigurement and local
refractory osteomyelitis were encountered, radical surgery
was indicated as treatment of choice. Following complete
resection, several reconstruction options were applied
including vascularized fibular and iliac flap to restore the
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facial profile and provide enough bone for staged osseoin-
tegrated dental implants.
As regard to prognostic factor for craniomaxillofacial
FD, in addition to age at the time of surgery, the possi-
bility of complete resection has been commonly empha-
sized. Recently, serum alkaline phosphatase (ALP) has
been proposed to be associated with recurrence fol-
lowing conservative surgery and potential malignant
transformation. It appeared as a reliable marker for pre-
dicting the progress and treatment outcome of cranio-
maxillofacial FD [22]. In our study, similar with previous
reports, the level of ALP was much higher in patient
than healthy controls. Additionally, levels of ALP in two
patients with malignant transformation were 4 and 10
folds higher than healthy controls respectively. However,
its levels in primary cases were comparable with that
in recurrent cases. Collectively, our results support this
notion that serum ALP is a useful biomarker for FD
diagnosis, but its values in prognostic prediction still
remain further validations.
In conclusion, craniomaxillofacial FD is a rare bone
disease with defined epidemiological and clinical traits
in Chinese population. The treatment of choice should
be tailed to every patient. Further investigations are
required to establish the optimized timing, treatment
choice and prognostic predictors for patients with
craniomaxillofacial FD.
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